{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:06:25Z","timestamp":1791511585956,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"FCT - Fundan\u00e7\u00e3o para a Ci\u00eancia e Tecnologia IP","award":["UIDB\/00276\/2020"],"award-info":[{"award-number":["UIDB\/00276\/2020"]}]},{"name":"AL4AnimalS","award":["LA\/P\/0059\/2020"],"award-info":[{"award-number":["LA\/P\/0059\/2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Allopurinol, one of the drugs routinely used to treat canine leishmaniosis (CanL), is an inhibitor of the enzyme xanthine oxidase, which plays a fundamental role in purine metabolism. Its inhibitory action on this enzyme leads to a state of hyperxanthinuria, favouring the development of xanthine crystals and\/or uroliths. However, not all dogs with CanL treated with allopurinol develop xanthinuria and\/or xanthine uroliths, and there is not much information on the possible risk factors that contribute to this event. This study aims to evaluate potential predisposing factors associated with the development of xanthinuria in dogs with a previous diagnosis of CanL that were treated with allopurinol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A multicentric, retrospective, observational study was conducted and included dogs with CanL undergoing allopurinol therapy. Dogs that developed xanthinuria (Xgroup) and those without xanthinuria (NXgroup) were selected from cases admitted to three referral hospitals between 2011 and 2022. Medical records were reviewed, and clinical and laboratorial variables were compared between groups. Descriptive statistics, contingency tables and non-parametric tests were used (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 90 dogs were selected, 45 for each group. Only age and serum alpha-1 globulin concentration were significantly different between groups at day 0. Dogs from Xgroup were younger (median 4\u00a0years; interquartile range (IQR) 2\u20137) than those from NXgroup (median 6\u00a0years; IQR 4\u20139;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002). At the time of CanL diagnosis, a higher percentage of dogs from NXgroup had decreased serum alpha-1 globulin concentrations (38.9% versus 13.3% in Xgroup, respectively;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.020). In Xgroup, the median time to xanthinuria development after starting allopurinol was 150\u00a0days (IQR 31\u2013455).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results suggest that closer monitoring of young dogs (&lt;\u20094\u00a0years) and those with normal alpha-1 globulin levels at diagnosis is recommended to ascertain the possible development of xanthinuria at an early stage, allowing for early application of measures to reduce the likelihood of its development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-025-06731-0","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:19:16Z","timestamp":1741609156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Characterisation and evaluation of predisposing factors for the development of xanthinuria in dogs with leishmaniosis under allopurinol therapy"],"prefix":"10.1186","volume":"18","author":[{"given":"Sara Clemente","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Dom\u00ednguez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Prosper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Joana","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo Oliveira","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"6731_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.20506\/rst.34.2.2384","volume":"34","author":"M Gharbi","year":"2015","unstructured":"Gharbi M, Mhadhbi M, Rejeb A, Jaouadi K, Rouatbi M, Darghouth MA. Leishmaniosis (Leishmania infantum infection) in dogs. Rev Sci Tech. 2015;34:613\u201326.","journal-title":"Rev Sci Tech"},{"key":"6731_CR2","first-page":"125","volume-title":"Arthropod-borne infectious diseases of the dog and cat","author":"L Solano-Gallego","year":"2016","unstructured":"Solano-Gallego L, Roura X, Baneth G. Leishmaniosis. In: Day MJ, editor. Arthropod-borne infectious diseases of the dog and cat. 2nd ed. CRC Press; 2016. p. 125\u201340.","edition":"2"},{"key":"6731_CR3","unstructured":"LeishVet (Consensus). Canine and feline leishmaniosis. 5th ed. 2022. https:\/\/www.leishvet.org\/wp-content\/uploads\/2022\/05\/ALIVE-may22-web-EN.pdf. Accessed 7 Mar 2025."},{"key":"6731_CR4","doi-asserted-by":"publisher","first-page":"3296893","DOI":"10.1155\/2018\/3296893","volume":"2018","author":"RR Ribeiro","year":"2018","unstructured":"Ribeiro RR, Michalick MSM, da Silva ME, Dos Santos CCP, Fr\u00e9zard FJG, da Silva SM. Canine leishmaniasis: an overview of the current status and strategies for control. Biomed Res Int. 2018;2018:3296893.","journal-title":"Biomed Res Int"},{"key":"6731_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13071-015-0896-0","volume":"8","author":"L Manna","year":"2015","unstructured":"Manna L, Corso R, Galiero G, Cerrone A, Muzj P, Gravino AE. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol. Parasit Vectors. 2015;8:289.","journal-title":"Parasit Vectors"},{"key":"6731_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13071-020-04544-x","volume":"14","author":"AI Ol\u00edas-Molero","year":"2021","unstructured":"Ol\u00edas-Molero AI, Font\u00e1n-Matilla E, Cuquerella M, Alunda JM. Scientometric analysis of chemotherapy of canine leishmaniasis (2000\u20132020). Parasit Vectors. 2021;14:36.","journal-title":"Parasit Vectors"},{"key":"6731_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s13071-021-04799-y","volume":"14","author":"M Monteiro","year":"2021","unstructured":"Monteiro M, Prata S, Cardoso L, da Fonseca IP, Leal RO. Diagnosis and clinical management of canine leishmaniosis by general veterinary practitioners: a questionnaire-based survey in Portugal. Parasit Vectors. 2021;14:306.","journal-title":"Parasit Vectors"},{"key":"6731_CR8","doi-asserted-by":"publisher","first-page":"100048","DOI":"10.1016\/j.jvacx.2019.100048","volume":"4","author":"LFM Nascimento","year":"2019","unstructured":"Nascimento LFM, Miranda DFH, Moura LD, Pinho FA, Werneck GL, Khouri R, et\u00a0al. Allopurinol therapy provides long term clinical improvement, but additional immunotherapy is required for sustained parasite clearance, in L. infantum-infected dogs. Vaccine X. 2019;4:100048.","journal-title":"Vaccine X"},{"key":"6731_CR9","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3390\/ani12060731","volume":"12","author":"MA Pereira","year":"2022","unstructured":"Pereira MA, Santos R, N\u00f3brega C, Mega C, Cruz R, Esteves F, et\u00a0al. A questionnaire-based survey on the long-term management of canine leishmaniosis by veterinary practitioners. Animals. 2022;12:731.","journal-title":"Animals"},{"key":"6731_CR10","volume-title":"Handbook of experimental pharmacology","year":"1978","unstructured":"Kelley WN, Weiner IM, editors. Handbook of experimental pharmacology. 1st ed. Berlin: Springer; 1978.","edition":"1"},{"key":"6731_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cvsm.2008.09.004","volume":"39","author":"CA Osborne","year":"2009","unstructured":"Osborne CA, Lulich JP, Swanson LL, Albasan H. Drug-induced urolithiasis. Vet Clin North Am Small Anim Pract. 2009;39:55\u201363.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"6731_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetpar.2013.03.010","volume":"195","author":"VS Belo","year":"2013","unstructured":"Belo VS, Struchiner CJ, Werneck GL, Barbosa DS, de Oliveira RB, Neto RG, et\u00a0al. A systematic review and meta-analysis of the factors associated with Leishmania infantum infection in dogs in Brazil. Vet Parasitol. 2013;195:1\u201313.","journal-title":"Vet Parasitol"},{"key":"6731_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244923","volume":"16","author":"P Rombol\u00e0","year":"2021","unstructured":"Rombol\u00e0 P, Barlozzari G, Carvelli A, Scarpulla M, Iacoponi F, Macr\u00ec G. Seroprevalence and risk factors associated with exposure to Leishmania infantum in dogs, in an endemic Mediterranean region. PLoS ONE. 2021;16:e0244923.","journal-title":"PLoS ONE"},{"key":"6731_CR14","doi-asserted-by":"publisher","first-page":"289300","DOI":"10.1007\/s00436-020-06973-0","volume":"120","author":"C Tamponi","year":"2021","unstructured":"Tamponi C, Scarpa F, Carta S, Knoll S, Sanna D, Gai C, et\u00a0al. Seroprevalence and risk factors associated with Leishmania infantum in dogs in Sardinia (Italy), an endemic island for leishmaniasis. Parasitol Res. 2021;120:289300.","journal-title":"Parasitol Res"},{"key":"6731_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1055\/a-1334-0733","volume":"49","author":"D Breu","year":"2021","unstructured":"Breu D, Stieger N, M\u00fcller E. Auftreten von Harnsteinen \u2013 alters-, rasse- und geschlechtsspezifische Unterschiede bei Hunden aus Deutschland [Occurrence of uroliths \u2013 age-, breed-, and gender-specific differences in dogs from Germany]. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2021;49:6\u201312.","journal-title":"Tierarztl Prax Ausg K Kleintiere Heimtiere"},{"key":"6731_CR16","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/jvim.16114","volume":"35","author":"L Kopecny","year":"2021","unstructured":"Kopecny L, Palm CA, Segev G, Westropp JL. Urolithiasis in dogs: evaluation of trends in urolith composition and risk factors (2006\u20132018). J Vet Intern Med. 2021;35:1406\u201315.","journal-title":"J Vet Intern Med"},{"key":"6731_CR17","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.3390\/ani11092579","volume":"11","author":"M Edo","year":"2021","unstructured":"Edo M, Mar\u00edn-Garc\u00eda PJ, Llobat L. Is the prevalence of Leishmania infantum linked to breeds in dogs? Characterization of seropositive dogs in Ibiza. Animals. 2021;11:2579.","journal-title":"Animals"},{"key":"6731_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13071-022-05226-6","volume":"15","author":"A M\u00fcller","year":"2022","unstructured":"M\u00fcller A, Montoya A, Escacena C, de la Cruz M, Junco A, Iriso A, et\u00a0al. Leishmania infantum infection serosurveillance in stray dogs inhabiting the Madrid community: 2007\u20132018. Parasit Vectors. 2022;15:96.","journal-title":"Parasit Vectors"},{"key":"6731_CR19","first-page":"833","volume-title":"Small animal clinical nutrition","author":"CA Osborne","year":"2010","unstructured":"Osborne CA, Bartges GW, Lulich JP, Albasan H, Weiss C. Canine purine urolithiasis: causes, detection, management and prevention. In: Hand MS, editor. Small animal clinical nutrition. 5th ed. Topeka: Mark Morris Institute; 2010. p. 833\u201353.","edition":"5"},{"key":"6731_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.rvsc.2021.04.026","volume":"137","author":"ND Burggraaf","year":"2021","unstructured":"Burggraaf ND, Westgeest DB, Corbee RJ. Analysis of 7866 feline and canine uroliths submitted between 2014 and 2020 in the Netherlands. Res Vet Sci. 2021;137:86\u201393.","journal-title":"Res Vet Sci"},{"key":"6731_CR21","unstructured":"Marques MILM. Leishmaniose canina [dissertation]. 2008."},{"key":"6731_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/jsap.12484","volume":"57","author":"M Torres","year":"2016","unstructured":"Torres M, Pastor J, Roura X, Tabar MD, Espada Y, Font A, et\u00a0al. Adverse urinary effects of allopurinol in dogs with leishmaniasis. J Small Anim Pract. 2016;57:299\u2013304.","journal-title":"J Small Anim Pract"},{"key":"6731_CR23","first-page":"128","volume":"7","author":"MA Pereira","year":"2020","unstructured":"Pereira MA, Santos R, Oliveira R, Costa L, Prata A, Gon\u00e7alves V, et\u00a0al. Prognostic factors and life expectancy in canine leishmaniosis. Vet Sci. 2020;7:128.","journal-title":"Vet Sci"},{"key":"6731_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0304-4017(02)00351-5","volume":"111","author":"JC Fran\u00e7a-Silva","year":"2003","unstructured":"Fran\u00e7a-Silva JC, da Costa RT, Siqueira AM, Machado-Coelho GL, da Costa CA, Mayrink W, et\u00a0al. Epidemiology of canine visceral leishmaniosis in the endemic area of Montes Claros Municipality, Minas Gerais State. Brazil Vet Parasitol. 2003;111:161\u201373.","journal-title":"Brazil Vet Parasitol"},{"key":"6731_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/jhered\/esi111","volume":"96","author":"E S\u00e1nchez-Robert","year":"2005","unstructured":"S\u00e1nchez-Robert E, Altet L, S\u00e1nchez A, Francino O. Polymorphism of Slc11a1 (Nramp1) gene and canine leishmaniasis in a case-control study. J Hered. 2005;96:755\u20138.","journal-title":"J Hered"},{"key":"6731_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1051\/vetres:2008013","volume":"39","author":"E S\u00e1nchez-Robert","year":"2008","unstructured":"S\u00e1nchez-Robert E, Altet L, Utzet-Sadurn\u00ed M, Giger U, S\u00e1nchez A, Francino O. Slc11a1 (formerly Nramp1) and susceptibility to canine visceral leishmaniasis. Vet Res. 2008;39:36.","journal-title":"Vet Res"},{"key":"6731_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104003","volume":"9","author":"NH Curi","year":"2014","unstructured":"Curi NH, Paschoal AM, Massara RL, Marcelino AP, Ribeiro AA, Passamani M, et\u00a0al. Factors associated with the seroprevalence of leishmaniasis in dogs living around Atlantic Forest fragments. PLoS ONE. 2014;9:e104003.","journal-title":"PLoS ONE"},{"key":"6731_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13071-020-04081-7","volume":"13","author":"R G\u00e1lvez","year":"2020","unstructured":"G\u00e1lvez R, Montoya A, Cruz I, Fern\u00e1ndez C, Mart\u00edn O, Checa R, et\u00a0al. Latest trends in Leishmania infantum infection in dogs in Spain, part I: mapped seroprevalence and sand fly distributions. Parasit Vectors. 2020;13:204.","journal-title":"Parasit Vectors"},{"key":"6731_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.prevetmed.2018.10.015","volume":"162","author":"R V\u00e9lez","year":"2019","unstructured":"V\u00e9lez R, Ballart C, Dom\u00e8nech E, Abras A, Fern\u00e1ndez-Ar\u00e9valo A, G\u00f3mez SA, et\u00a0al. Seroprevalence of canine Leishmania infantum infection in the Mediterranean region and identification of risk factors: the example of North-Eastern and Pyrenean areas of Spain. Prev Vet Med. 2019;162:67\u201375.","journal-title":"Prev Vet Med"},{"key":"6731_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s13105-011-0100-8","volume":"67","author":"C Vida","year":"2011","unstructured":"Vida C, Corpas I, De la Fuente M, Gonz\u00e1lez EM. Age-related changes in xanthine oxidase activity and lipid peroxidation, as well as in the correlation between both parameters, in plasma and several organs from female mice. J Physiol Biochem. 2011;67:551\u20138.","journal-title":"J Physiol Biochem"},{"key":"6731_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10522-011-9351-6","volume":"12","author":"C Vida","year":"2011","unstructured":"Vida C, Rodr\u00edguez-Ter\u00e9s S, Heras V, Corpas I, De la Fuente M, Gonz\u00e1lez E. The aged-related increase in xanthine oxidase expression and activity in several tissues from mice is not shown in long-lived animals. Biogerontology. 2011;12:551\u201364.","journal-title":"Biogerontology"},{"key":"6731_CR32","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/antiox9090839","volume":"9","author":"MG Battelli","year":"2020","unstructured":"Battelli MG, Bortolotti M, Bolognesi A, Polito L. Pro-aging effects of xanthine oxidoreductase products. Antioxid. 2020;9:839.","journal-title":"Antioxid"},{"key":"6731_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/art.1780230113","volume":"23","author":"DJ Levinson","year":"1980","unstructured":"Levinson DJ, Chalker D. Rat hepatic xanthine oxidase activity: age and sex specific differences. Arthritis Rheum. 1980;23:77\u201382.","journal-title":"Arthritis Rheum"},{"key":"6731_CR34","doi-asserted-by":"publisher","first-page":"6304127","DOI":"10.1155\/2021\/6304127","volume":"2021","author":"H Idrissi","year":"2021","unstructured":"Idrissi H, Hakkour M, Duchateau L, Zanatta R, Kachani M, Azrib R, et\u00a0al. Canine leishmaniasis in Morocco: a descriptive prospective clinical study. Vet Med Int. 2021;2021:6304127.","journal-title":"Vet Med Int"},{"key":"6731_CR35","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/vcp.12413","volume":"45","author":"S Paltrinieri","year":"2016","unstructured":"Paltrinieri S, Gradoni L, Roura X, Zatelli A, Zini E. Laboratory tests for diagnosing and monitoring canine leishmaniasis. Vet Clin Pathol. 2016;45:552\u201378.","journal-title":"Vet Clin Pathol"},{"key":"6731_CR36","first-page":"475","volume":"61","author":"C T\u00f3thov\u00e1","year":"2016","unstructured":"T\u00f3thov\u00e1 C, Nagy O, Kov\u00e1\u010d G. Serum proteins and their diagnostic utility in veterinary medicine: a review. CAAS Agric J. 2016;61:475\u201396.","journal-title":"CAAS Agric J"},{"key":"6731_CR37","first-page":"300","volume":"5","author":"ADF da Silva","year":"2011","unstructured":"da Silva ADF, Lima MCJS, Soto-Blanco B. Perfil hematol\u00f3gico e eletrofor\u00e9tico de prote\u00ednas s\u00e9ricas em c\u00e3es soropositivos para leishmaniose visceral no estado do Rio Grande do Norte. Acta Vet Bras. 2011;5:300\u20135.","journal-title":"Acta Vet Bras"},{"key":"6731_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13071-023-05777-2","volume":"16","author":"MK de Jong","year":"2023","unstructured":"de Jong MK, Rappoldt A, Broere F, Piek CJ. Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy. Parasit Vectors. 2023;16:163.","journal-title":"Parasit Vectors"},{"key":"6731_CR39","unstructured":"Maroco J. An\u00e1lise estat\u00edstica com utiliza\u00e7\u00e3o do SPSS. 3rd ed. 2007."},{"key":"6731_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/jvp.12899","volume":"44","author":"AP Costa","year":"2021","unstructured":"Costa AP, Court MH, Villarino NF, Burke NS, Mealey KL. Canine orosomucoid (alpha-1 acid glycoprotein) variants and their influence on drug plasma protein binding. J Vet Pharmacol Ther. 2021;44:116\u201325.","journal-title":"J Vet Pharmacol Ther"},{"key":"6731_CR41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13105-015-0389-9","volume":"71","author":"Z Luo","year":"2015","unstructured":"Luo Z, Lei H, Sun Y, Liu X, Su DF. Orosomucoid, an acute response protein with multiple modulating activities. J Physiol Biochem. 2015;71:329\u201340.","journal-title":"J Physiol Biochem"},{"key":"6731_CR42","unstructured":"MSD Manual. University of California San Diego: Skaggs School of Pharmacy and Pharmaceutical Sciences; 2022."},{"key":"6731_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF00606429","volume":"22","author":"B Breithaupt","year":"1982","unstructured":"Breithaupt B, Tittel M. Kinetics of allopurinol after single intravenous and oral doses: noninteraction with benzbromarone and hydrochlorothiazide. Eur J Clin Pharmacol. 1982;22:77\u201384.","journal-title":"Eur J Clin Pharmacol"},{"key":"6731_CR44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1365-2125.1974.tb00220.x","volume":"1","author":"BM Dean","year":"1974","unstructured":"Dean BM, Perrett D, Simmonds HA, Grahame R. Thiopurinol: comparative enzyme inhibition and protein binding studies with allopurinol, oxipurinol and 6-mercaptopurine. Br J Clin Pharmacol. 1974;1:119\u201327.","journal-title":"Br J Clin Pharmacol"},{"key":"6731_CR45","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/0006-2952(66)90163-8","volume":"15","author":"GB Elion","year":"1966","unstructured":"Elion GB, Kovensky A, Hitchings GH. Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochem Pharmacol. 1966;15:863\u201380.","journal-title":"Biochem Pharmacol"},{"key":"6731_CR46","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.tvjl.2010.05.025","volume":"188","author":"M Torres","year":"2011","unstructured":"Torres M, Bardag\u00ed M, Roura X, Zanna G, Ravera I, Ferrer L. Long-term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol. Vet J. 2011;188:346\u201351.","journal-title":"Vet J"},{"key":"6731_CR47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.vetpar.2017.04.014","volume":"239","author":"S Segarra","year":"2017","unstructured":"Segarra S, Mir\u00f3 G, Montoya A, Pardo-Mar\u00edn L, Boqu\u00e9 N, Ferrer L, et\u00a0al. Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis. Vet Parasitol. 2017;239:50\u20136.","journal-title":"Vet Parasitol"},{"key":"6731_CR48","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/vr.143.15.420","volume":"143","author":"T Flegel","year":"1998","unstructured":"Flegel T, Freistadt R, Haider W. Xanthine urolithiasis in a dachshund. Vet Rec. 1998;143:420\u20133.","journal-title":"Vet Rec"},{"key":"6731_CR49","unstructured":"Simmonds HA. Hereditary xanthinuria. Orphanet Encycl. 2003."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06731-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-06731-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06731-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:19:25Z","timestamp":1741609165000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-025-06731-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6731"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-06731-0","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not applicable in view of the retrospective nature of the study and all the procedures being performed were part of the routine care and conducted after individual agreement of owners.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"98"}}